BREAKING

LIVEPLFS July 2026: 55.4% LFPR, 52.5% WPR, 5.1% UR LIVETrump Orders Major Cut to South Korea Military Drills LIVERBI Reports $56,846 Million Forex Inflows in 2026 LIVEWPI Inflation July 2026 Eases to 9.78% From 9.87%LIVEIndia Exports July 2026 Rise 13.31% to US$80.14 Billion LIVEManufacturing GVA CAGR Hits 10.88% From 2022-23 to 2025-26 LIVEIndia CPI Inflation Rises to 4.45% in July 2026 LIVEIEA Oil Demand: 2026 Global Demand Forecast Cut 1.6M bpd LIVEF&O Retail Investor Losses: 78.6 Lakh Traders Lost Rs 91,685 Crore in FY26 LIVEGautam Adani SEC Judgment: $6 Million US Court Order LIVEPLFS July 2026: 55.4% LFPR, 52.5% WPR, 5.1% UR LIVETrump Orders Major Cut to South Korea Military Drills LIVERBI Reports $56,846 Million Forex Inflows in 2026 LIVEWPI Inflation July 2026 Eases to 9.78% From 9.87%LIVEIndia Exports July 2026 Rise 13.31% to US$80.14 Billion LIVEManufacturing GVA CAGR Hits 10.88% From 2022-23 to 2025-26 LIVEIndia CPI Inflation Rises to 4.45% in July 2026 LIVEIEA Oil Demand: 2026 Global Demand Forecast Cut 1.6M bpd LIVEF&O Retail Investor Losses: 78.6 Lakh Traders Lost Rs 91,685 Crore in FY26 LIVEGautam Adani SEC Judgment: $6 Million US Court Order

Breaking News Desk Editorial

Motilal Oswal Recommends BUY on PPL Pharma with Target Price of Rs 260

bigbreakingwire

9/30/2024 1 min read

Motilal Oswal has issued a BUY recommendation on PPL Pharma with a target price of Rs 260, indicating a potential upside of 14.89% from the current price of Rs 226.31.

Related

bigbreakingwire

Author & Editorial Desk

bigbreakingwire

Bringing you the latest updates on finance, economies, stocks, bonds, and more. Stay informed with timely insights.

View All Articles By Author